|
| Press Releases |
|
 |
|
| Tuesday, September 24, 2024 |
|
|
China Medical System: New Drug Application for Vitiligo Indication of Ruxolitinib Phosphate Cream Accepted in China |
| China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on September 24, 2024, the New Drug Application (NDA) for vitiligo indication of ruxolitinib phosphate cream (the "ruxolitinib cream" or the "Product") has been accepted by the National Medical Products Administration of China (NMPA). more info >> |
|
| Friday, August 16, 2024 |
|
|
China Medical System (00867) Released its 2024 Interim Results: Steady Increase in Revenue and Profit Compared with 2H 2023 |
| On August 15, 2024, China Medical System Holdings Limited ("CMS" or the "Company") released its 2024 interim results announcement, with a steady increase in overall revenue and profit for the period compared to the second half (2H) of 2023. In the first half (1H) of 2024, the Company recorded a turnover of RMB3,611.1 million, representing a decrease of 21.7% compared with 1H 2023, an increase of 6.1% compared with 2H 2023. more info >> |
|
| Monday, August 5, 2024 |
|
|
China Medical System: NDA for Additional Rheumatoid Arthritis Indication of Methotrexate Injection Approved in China |
| China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 30 July 2024, the New Drug Application (NDA) for an additional indication of Methotrexate Injection (the "Product") has been approved by the National Medical Products Administration of China (NMPA). more info >> |
|
| Tuesday, July 16, 2024 |
|
|
China Medical System (867.HK) Reincluded in S&P Global Sustainability Yearbook (China Edition) and Maintained MSCI ESG "AA" Rating |
| In July 2024, China Medical System Holdings Limited ("CMS" or the "Group") has once again been recognized for its outstanding performance and continuous progress in sustainable development. more info >> |
|
| Tuesday, June 25, 2024 |
|
|
China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitinib Cream in Atopic Dermatitis in China |
| On June 25, China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") announced the completion of dosing for the first subject in the phase III bridging trial of ruxolitinib cream (the "Product") in atopic dermatitis ("AD") in China. more info >> |
|
| Tuesday, June 18, 2024 |
|
|
China Medical System: Innovative Drug Methylthioninium Chloride Enteric-coated Sustained-release Tablets Approved for Marketing in China |
| more info >> |
|
| Tuesday, April 23, 2024 |
|
|
China Medical System: New Drug Application of Desidustat Tablets Accepted in China |
| China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that on 22 April 2024, the New Drug Application (NDA) of Desidustat Tablets ("Desidustat Tablets" or the "Product") has been accepted by the National Medical Products Administration of China (NMPA). more info >> |
|
| Monday, April 1, 2024 |
|
|
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia |
| more info >> |
|
| Thursday, March 28, 2024 |
|
|
China Medical System (867.HK) 2023 Annual Results: Despite of the Temporary Financial Performance Pressure, Fresh Catalysts Emerged from Successive Innovation Breakthroughs |
| more info >> |
|
| Sunday, February 4, 2024 |
|
|
China Medical System (00867) Obtained Exclusive License of a First-line Phosphate-lowering Drug Velphoro(R) |
| more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
Hong Kong Films @ Busan 2024 opens tomorrow
Oct 4, 2024 22:00 HKT/SGT
|
|
|
Antidote Announces $100M for Community Building and User Rewards 
Oct 4, 2024 19:00 HKT/SGT
|
|
|
Indonesia's Path to Society 5.0: Driving Digital Innovation at the Digital Transformation Summit
Oct 4, 2024 15:34 HKT/SGT
|
|
|
Pluk Phak Praw Rak Mae PCL (SET: OKJ) Eyes Expansion as the 'King of Organic Salad'
Oct 4, 2024 14:00 HKT/SGT
|
|
|
Fujitsu highlights technologies to realize its vision of AI as a trusted assistant at CEATEC 2024
Oct 4, 2024 11:03 JST
|
|
|
Four major tech fairs open in October
Oct 3, 2024 22:09 HKT/SGT
|
|
|
AVIA Announces "Vietnam in View" Conference, Highlighting Growth and Opportunities in Vietnam's Media and Entertainment Industry
Oct 3, 2024 19:30 HKT/SGT
|
|
|
ALUXE Unveils Enchanting New Winnie the Pooh Wedding Ring Collection
Oct 3, 2024 17:00 HKT/SGT
|
|
|
Toyota to Invest $500 Million in Joby Aviation
Oct 3, 2024 15:59 JST
|
|
|
CisgenX Awarded Smart Approved WaterMark Certification for Innovative Irrigation Solutions
Oct 3, 2024 14:47 HKT/SGT
|
|
|
Spa IZUMI Launches "YON-KA Phyto Sleep Ritual"
Oct 3, 2024 12:00 HKT/SGT
|
|
|
ADvance Pilipinas: "The Future of Advertising: Convergence and Divergence"
Oct 3, 2024 11:08 HKT/SGT
|
|
|
Fujitsu and Supermicro announce strategic collaboration to develop green AI computing technology and liquid-cooled datacenter solutions
Oct 3, 2024 9:38 JST
|
|
|
Insightful Discussions on eMobility Await: Join Influential Speakers at London EV Show 2024
Oct 2, 2024 18:36 HKT/SGT
|
|
|
Wadaoki Forest at the Mihara Machinery Works Certified as 'Nationally Certified Sustainably Managed Natural Site' by Ministry of the Environment
Oct 2, 2024 14:42 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
